Cargando…
Neuroprotection for Ischemic Stroke: Moving Past Shortcomings and Identifying Promising Directions
The translation of neuroprotective agents for ischemic stroke from bench-to-bedside has largely failed to produce improved treatments since the development of tissue plasminogen activator (tPA). One possible reason for lack of translation is the failure to acknowledge the greatest risk factor for st...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565354/ https://www.ncbi.nlm.nih.gov/pubmed/23344061 http://dx.doi.org/10.3390/ijms14011890 |